Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1967 1
1968 4
1969 4
1970 4
1971 5
1972 25
1973 32
1974 29
1975 32
1976 39
1977 45
1978 32
1979 30
1980 43
1981 28
1982 31
1983 29
1984 34
1985 45
1986 35
1987 33
1988 43
1989 41
1990 53
1991 43
1992 45
1993 47
1994 64
1995 63
1996 73
1997 63
1998 72
1999 53
2000 66
2001 84
2002 139
2003 204
2004 252
2005 415
2006 499
2007 634
2008 817
2009 972
2010 1090
2011 1131
2012 1319
2013 1552
2014 1754
2015 1776
2016 2091
2017 2354
2018 2496
2019 2615
2020 2789
2021 3153
2022 3163
2023 2840
2024 892

Text availability

Article attribute

Article type

Publication date

Search Results

31,236 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of Diabetic Kidney Disease: Current and Future.
Yamazaki T, Mimura I, Tanaka T, Nangaku M. Yamazaki T, et al. Diabetes Metab J. 2021 Jan;45(1):11-26. doi: 10.4093/dmj.2020.0217. Epub 2021 Jan 22. Diabetes Metab J. 2021. PMID: 33508907 Free PMC article. Review.
Diabetic kidney disease (DKD) is the major cause of end-stage kidney disease. ...Furthermore, NF-E2-related factor 2 activators improved the glomerular filtration rate of DKD patients in Bardoxolone Methyl Treatment: Renal Function in chronic kidney …
Diabetic kidney disease (DKD) is the major cause of end-stage kidney disease. ...Furthermore, NF-E2-related fact …
Prediabetes and What It Means: The Epidemiological Evidence.
Echouffo-Tcheugui JB, Selvin E. Echouffo-Tcheugui JB, et al. Annu Rev Public Health. 2021 Apr 1;42:59-77. doi: 10.1146/annurev-publhealth-090419-102644. Epub 2021 Dec 23. Annu Rev Public Health. 2021. PMID: 33355476 Free PMC article. Review.
Risks of major complications in persons with prediabetes, including diabetes, cardiovascular disease, kidney disease, and death, also vary depending on the prediabetes definition used. Randomized clinical trials have demonstrated that lifestyle and pha …
Risks of major complications in persons with prediabetes, including diabetes, cardiovascular disease, kidney disease, and deat …
Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease.
Zheng J, Zhang Y, Rasheed H, Walker V, Sugawara Y, Li J, Leng Y, Elsworth B, Wootton RE, Fang S, Yang Q, Burgess S, Haycock PC, Borges MC, Cho Y, Carnegie R, Howell A, Robinson J, Thomas LF, Brumpton BM, Hveem K, Hallan S, Franceschini N, Morris AP, Köttgen A, Pattaro C, Wuttke M, Yamamoto M, Kashihara N, Akiyama M, Kanai M, Matsuda K, Kamatani Y, Okada Y, Walters R, Millwood IY, Chen Z, Davey Smith G, Barbour S, Yu C, Åsvold BO, Zhang H, Gaunt TR. Zheng J, et al. Int J Epidemiol. 2022 Jan 6;50(6):1995-2010. doi: 10.1093/ije/dyab203. Epub 2021 Oct 20. Int J Epidemiol. 2022. PMID: 34999880 Free PMC article.
BACKGROUND: This study was to systematically test whether previously reported risk factors for chronic kidney disease (CKD) are causally related to CKD in European and East Asian ancestries using Mendelian randomization. METHODS: A total of 45 risk factors wi …
BACKGROUND: This study was to systematically test whether previously reported risk factors for chronic kidney disease (CKD) ar …
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME. Jagasia MH, et al. Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18. Biol Blood Marrow Transplant. 2015. PMID: 25529383 Free PMC article.
Categories of chronic GVHD should be defined in ways that indicate prognosis, guide treatment, and define eligibility for clinical trials. Revisions have been made to focus attention on the causes of organ-specific abnormalities. ...
Categories of chronic GVHD should be defined in ways that indicate prognosis, guide treatment, and define eligibility for clinical tr …
Physical activity in chronic kidney disease and the EXerCise Introduction To Enhance trial.
Mallamaci F, Pisano A, Tripepi G. Mallamaci F, et al. Nephrol Dial Transplant. 2020 Mar 1;35(Suppl 2):ii18-ii22. doi: 10.1093/ndt/gfaa012. Nephrol Dial Transplant. 2020. PMID: 32162664 Free PMC article. Review.
It is well known from observational studies that sedentary lifestyle and reduced physical activity are common in dialysis and chronic kidney disease (CKD) patients and associate with an increased risk of morbidity and mortality in this patient population. ...On the …
It is well known from observational studies that sedentary lifestyle and reduced physical activity are common in dialysis and chronic kid …
Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials.
Garcia Sanchez JJ, Thompson J, Scott DA, Evans R, Rao N, Sörstadius E, James G, Nolan S, Wittbrodt ET, Abdul Sultan A, Stefansson BV, Jackson D, Abrams KR. Garcia Sanchez JJ, et al. Adv Ther. 2022 Jan;39(1):193-220. doi: 10.1007/s12325-021-02006-z. Epub 2021 Dec 8. Adv Ther. 2022. PMID: 34881414 Free PMC article. Review.
Delaying disease progression and reducing the risk of mortality are key goals in the treatment of chronic kidney disease (CKD). New drug classes to augment renin-angiotensin-aldosterone system (RAAS) inhibitors as the standard of care have scarcely met their primary …
Delaying disease progression and reducing the risk of mortality are key goals in the treatment of chronic kidney disease (CKD) …
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications.
Heerspink HJ, Perkins BA, Fitchett DH, Husain M, Cherney DZ. Heerspink HJ, et al. Circulation. 2016 Sep 6;134(10):752-72. doi: 10.1161/CIRCULATIONAHA.116.021887. Epub 2016 Jul 28. Circulation. 2016. PMID: 27470878 Review.
On the basis of reduced glomerular filtration, glycosuric and weight loss effects are attenuated in patients with chronic kidney disease (estimated glomerular filtration rate <60 mL.min(-1).1.73 m(-2)). In contrast, blood pressure lowering, estimated glomerular f …
On the basis of reduced glomerular filtration, glycosuric and weight loss effects are attenuated in patients with chronic kidney d …
Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.
Thurber KM, Otto AO, Stricker SL. Thurber KM, et al. Am J Health Syst Pharm. 2023 Apr 8;80(8):487-494. doi: 10.1093/ajhp/zxad009. Am J Health Syst Pharm. 2023. PMID: 36629265 Review.
SUMMARY: Associations between PPIs and the following have been described: bone fracture, acute and chronic kidney disease, gastrointestinal infections, deficiencies in vitamin B12 and magnesium, and coronavirus disease 2019 and respiratory infections. ...In the only …
SUMMARY: Associations between PPIs and the following have been described: bone fracture, acute and chronic kidney disease, gas …
EditorialAssignment.
Xu Y, Yang Q, Fu C, Han E, Gao Y. Xu Y, et al. BMJ Open. 2023 Jan 18;13(1):e064220. doi: 10.1136/bmjopen-2022-064220. BMJ Open. 2023. PMID: 36657752 Free PMC article.
Rituximab has been recommended in the treatment of PMN by the updated Kidney Disease Improved Outcome guideline. However, the optimal dosing regimen of rituximab for the initial treatment of patients with PMN is unclear. ...The secondary outcomes are remission rate …
Rituximab has been recommended in the treatment of PMN by the updated Kidney Disease Improved Outcome guideline. However, the …
Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association: Endorsed by the American Society of Transplantation.
Cheng XS, VanWagner LB, Costa SP, Axelrod DA, Bangalore S, Norman SP, Herzog CA, Lentine KL; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Cardiovascular Radiology and Intervention. Cheng XS, et al. Circulation. 2022 Nov 22;146(21):e299-e324. doi: 10.1161/CIR.0000000000001104. Epub 2022 Oct 17. Circulation. 2022. PMID: 36252095 Free PMC article. Review.
Risk stratification algorithms based on the presence or absence of clinical risk factors and physical performance have been proposed, but a high proportion of candidates still meet criteria for screening tests. ...Emerging evidence such as results of the 2020 International …
Risk stratification algorithms based on the presence or absence of clinical risk factors and physical performance have been proposed, …
31,236 results
You have reached the last available page of results. Please see the User Guide for more information.